2-(2-{2-[2-(2-{[1-(2-Acetylamino-3-hydroxy-propionyl)-pyrrolidine-2-carbonyl]-amino}-3-phenyl-propionylamino)-5-guanidino-pentanoylamino]-3-hydroxy-propionylamino}-3-methyl-butyrylamino)-pentanedioic acid diamide

ID: ALA320363

Chembl Id: CHEMBL320363

PubChem CID: 14999603

Max Phase: Preclinical

Molecular Formula: C38H60N12O11

Molecular Weight: 860.97

Molecule Type: Protein

Associated Items:

Names and Identifiers

Canonical SMILES:  CC(=O)N[C@@H](CO)C(=O)N1CCC[C@H]1C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CCCN=C(N)N)C(=O)N[C@@H](CO)C(=O)N[C@H](C(=O)N[C@@H](CCC(N)=O)C(N)=O)C(C)C

Standard InChI:  InChI=1S/C38H60N12O11/c1-20(2)30(36(60)45-23(31(40)55)13-14-29(39)54)49-34(58)26(18-51)48-32(56)24(11-7-15-43-38(41)42)46-33(57)25(17-22-9-5-4-6-10-22)47-35(59)28-12-8-16-50(28)37(61)27(19-52)44-21(3)53/h4-6,9-10,20,23-28,30,51-52H,7-8,11-19H2,1-3H3,(H2,39,54)(H2,40,55)(H,44,53)(H,45,60)(H,46,57)(H,47,59)(H,48,56)(H,49,58)(H4,41,42,43)/t23-,24-,25-,26-,27-,28-,30-/m0/s1

Standard InChI Key:  QSTGVQKXZHJTND-LETOBRCSSA-N

Alternative Forms

Associated Targets(non-human)

Kallikrein 1 (28 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Molecule Features

Natural Product: NoOral: NoChemical Probe: NoParenteral: No
Molecule Type: ProteinTopical: NoFirst In Class: NoBlack Box: No
Chirality: NoAvailability: NoProdrug: No

Drug Indications

MESH IDMESH Heading EFO IDsEFO TermsMax Phase for IndicationReferences

Mechanisms of Action

Mechanism of ActionAction Typetarget IDTarget NameTarget TypeTarget OrganismBinding Site NameReferences

Calculated Properties

Molecular Weight: 860.97Molecular Weight (Monoisotopic): 860.4505AlogP: -5.41#Rotatable Bonds: 25
Polar Surface Area: 385.95Molecular Species: BASEHBA: 12HBD: 12
#RO5 Violations: 3HBA (Lipinski): 23HBD (Lipinski): 16#RO5 Violations (Lipinski): 3
CX Acidic pKa: 11.46CX Basic pKa: 10.78CX LogP: -6.50CX LogD: -8.56
Aromatic Rings: 1Heavy Atoms: 61QED Weighted: 0.02Np Likeness Score: 0.10

References

1. Deshpande MS, Burton J..  (1992)  Mapping the binding site of tissue kallikrein: preparation and testing of all possible substrate analog inhibitors homologous with the sequence of kininogen between Ser386 and Gln392.,  35  (17): [PMID:1507198] [10.1021/jm00095a002]

Source